All Stories

  1. Sensitivity to chromosomal breakage as risk factor in young adults with oral squamous cell carcinoma

    Article • Journal of Oral Pathology and Medicine, August 2015, Wiley

    Dr Boudewijn J Braakhuis

  2. Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients

    Article • Cancer Prevention Research, August 2015, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  3. Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs secondary primary tumor

    Article • Oral Oncology, August 2015, Elsevier

    Dr Boudewijn J Braakhuis

  4. Interaction of quantitative 18 F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

    Article • Head & Neck, May 2015, Wiley

    Dr Boudewijn J Braakhuis

  5. Quantitative Diffusion-Weighted MRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma

    Article • American Journal of Neuroradiology, February 2015, American Society of Neuroradiology (ASNR)

    Dr Boudewijn J Braakhuis

  6. A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?

    Article • Supportive Care in Cancer, August 2014, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  7. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011

    Article • Oral Oncology, July 2014, Elsevier

    Dr Boudewijn J Braakhuis

  8. Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2014, Elsevier

    Dr Boudewijn J Braakhuis

  9. Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer

    Article • European Journal of Cancer, March 2014, Elsevier

    Dr Boudewijn J Braakhuis

  10. Molecular screening of oral precancer

    Article • Oral Oncology, December 2013, Elsevier

    Dr Boudewijn J Braakhuis

  11. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas

    Article • International Journal of Cancer, November 2013, Wiley

    Dr Boudewijn J Braakhuis

  12. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors

    Article • Journal of Oral Pathology and Medicine, October 2013, Wiley

    Dr Boudewijn J Braakhuis

  13. TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients

    Article • Oral Diseases, September 2013, Wiley

    Dr Boudewijn J Braakhuis

  14. Identification of Lethal microRNAs Specific for Head and Neck Cancer

    Article • Clinical Cancer Research, August 2013, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  15. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines

    Article • Oral Oncology, June 2013, Elsevier

    Dr Boudewijn J Braakhuis

  16. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties

    Article • Stem Cell Research, May 2013, Elsevier

    Dr Boudewijn J Braakhuis

  17. DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

    Article • PLoS ONE, April 2013, PLOS

    Dr Boudewijn J Braakhuis, Professor Godefridus J Peters

  18. Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer

    Article • Clinical Cancer Research, February 2013, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  19. Immunotherapy for head and neck cancer patients: shifting the balance

    Article • Immunotherapy, January 2013, Future Medicine

    Dr Boudewijn J Braakhuis

  20. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients

    Article • Oral Diseases, November 2012, Wiley

    Dr Boudewijn J Braakhuis

  21. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

    Article • International Journal of Cancer, November 2012, Wiley

    Dr Boudewijn J Braakhuis

  22. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma

    Article • Oral Diseases, October 2012, Wiley

    Dr Boudewijn J Braakhuis

  23. Molecular diagnosis of minimal residual disease in head and neck cancer patients

    Article • Cellular Oncology, September 2012, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  24. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

    Article • Annals of Oncology, September 2012, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  25. Występowanie i rola aktywnej infekcji wirusem brodawczaka ludzkiego (HPV) w rakach płaskonabłonkowych głowy i szyi

    Article • Otolaryngologia Polska, July 2012, Index Copernicus

    Dr Boudewijn J Braakhuis

  26. Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers

    Article • Head & Neck, June 2012, Wiley

    Dr Boudewijn J Braakhuis

  27. Prognostic value of DNA ploidy status in patients with oral leukoplakia

    Article • Oral Oncology, October 2011, Elsevier

    Dr Boudewijn J Braakhuis

  28. Response to correspondence on the molecular biology of head and neck cancer

    Article • Nature Reviews Drug Discovery, May 2011, Nature

    Dr Boudewijn J Braakhuis

  29. Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma

    Article • Clinical Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  30. The molecular biology of head and neck cancer

    Article • Nature Reviews Drug Discovery, December 2010, Nature

    Dr Boudewijn J Braakhuis

  31. Molecular analysis of surgical margins in head and neck cancer: More than a marginal issue

    Article • Oral Oncology, July 2010, Elsevier

    Dr Boudewijn J Braakhuis

  32. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma

    Article • International Journal of Cancer, June 2010, Wiley

    Dr Boudewijn J Braakhuis

  33. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways

    Article • International Journal of Cancer, May 2010, Wiley

    Dr Boudewijn J Braakhuis

  34. Gene expression profiling in head and neck squamous cell carcinoma

    Article • Current Opinion in Otolaryngology & Head & Neck Surgery, April 2010, Wolters Kluwer Health

    Dr Boudewijn J Braakhuis

  35. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia

    Article • Oral Oncology, February 2010, Elsevier

    Dr Boudewijn J Braakhuis

  36. Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas

    Article • Clinical Cancer Research, December 2009, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  37. Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance

    Article • European Journal of Cancer, November 2009, Elsevier

    Dr Boudewijn J Braakhuis

  38. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults

    Article • Oral Oncology, September 2009, Elsevier

    Dr Boudewijn J Braakhuis

  39. Screening for Oral Precancer with Noninvasive Genetic Cytology

    Article • Cancer Prevention Research, January 2009, American Association for Cancer Research (AACR)

    Dr Boudewijn J Braakhuis

  40. Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck

    Article • BMC Medical Genomics, January 2009, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  41. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

    Article • Genes Chromosomes and Cancer, October 2008, Wiley

    Dr Boudewijn J Braakhuis

  42. Comparative evaluation of genetic assays to identify oral pre-cancerous fields

    Article • Journal of Oral Pathology and Medicine, August 2008, Wiley

    Dr Boudewijn J Braakhuis

  43. Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma

    Article • Journal of Clinical Pathology, April 2006, BMJ

    Dr Boudewijn J Braakhuis

  44. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

    Article • Oncogene, November 2005, Nature

    Dr Boudewijn J Braakhuis

  45. A noninvasive genetic screening test to detect oral preneoplastic lesions

    Article • Laboratory Investigation, August 2005, Nature

    Dr Boudewijn J Braakhuis

  46. Second Field Tumors: A New Opportunity for Cancer Prevention?

    Article • The Oncologist, August 2005, Alphamed Press

    Dr Boudewijn J Braakhuis

  47. Head and neck cancer: molecular carcinogenesis

    Article • Annals of Oncology, June 2005, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  48. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis

    Article • Seminars in Cancer Biology, April 2005, Elsevier

    Dr Boudewijn J Braakhuis

  49. Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus

    Article • JNCI Journal of the National Cancer Institute, July 2004, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  50. A genetic progression model of oral cancer: current evidence and clinical implications

    Article • Journal of Oral Pathology and Medicine, June 2004, Wiley

    Dr Boudewijn J Braakhuis

  51. Using tissue adjacent to carcinoma as a normal control: an obvious but questionable practice

    Article • The Journal of Pathology, May 2004, Wiley

    Dr Boudewijn J Braakhuis

  52. TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia

    Article • JNCI Journal of the National Cancer Institute, February 2004, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  53. Comparison of bleomycin and radiation in the G2 assay of chromatid breaks

    Article • International Journal of Radiation Biology, August 2003, Taylor & Francis

    Dr Boudewijn J Braakhuis

  54. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx

    Article • The Journal of Pathology, January 2003, Wiley

    Dr Boudewijn J Braakhuis

  55. Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer

    Article • Oral Oncology, September 2002, Elsevier

    Dr Boudewijn J Braakhuis

  56. Multiple Head and Neck Tumors Frequently Originate from a Single Preneoplastic Lesion

    Article • American Journal Of Pathology, September 2002, Elsevier

    Dr Boudewijn J Braakhuis

  57. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitionsCarl H. Synderman, MD, Section Editor

    Article • Head & Neck, February 2002, Wiley

    Dr Boudewijn J Braakhuis

  58. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of theTP53 gene

    Article • Genes Chromosomes and Cancer, January 2002, Wiley

    Dr Boudewijn J Braakhuis

  59. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions

    Article • Head & Neck, January 2002, Wiley

    Dr Boudewijn J Braakhuis

  60. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity

    Article • Environmental and Molecular Mutagenesis, January 2002, Wiley

    Dr Boudewijn J Braakhuis

  61. Nonmalignant Oral Keratinocytes from Patients with Head and Neck Squamous Cell Carcinoma Show Enhanced Metabolism of Retinoic Acid

    Article • Oncology, January 2002, Karger Publishers

    Dr Boudewijn J Braakhuis

  62. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines

    Article • International Journal of Cancer, January 2001, Wiley

    Dr Boudewijn J Braakhuis

  63. Mutagen sensitivity in patients with familial and non‐familial urothelial cell carcinoma

    Article • International Journal of Cancer, November 2000, Wiley

    Dr Boudewijn J Braakhuis

  64. Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma

    Article • International Journal of Cancer, January 2000, Wiley

    Dr Boudewijn J Braakhuis

  65. Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes

    Article • JNCI Journal of the National Cancer Institute, July 1999, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  66. Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome

    Article • Melanoma Research, June 1999, Wolters Kluwer Health

    Dr Boudewijn J Braakhuis

  67. Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa of the upper-aerodigestive tract

    Article • Cancer Letters, April 1999, Elsevier

    Dr Boudewijn J Braakhuis

  68. Plasma retinoid levels in head and neck cancer patients: a comparison with healthy controls and the effect of retinyl palmitate treatment

    Article • Oral Oncology, January 1999, Elsevier

    Dr Boudewijn J Braakhuis

  69. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

    Article • The Journal of Pathology, April 1998, Wiley

    Dr Boudewijn J Braakhuis

  70. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

    Article • The Journal of Pathology, April 1998, Wiley

    Dr Boudewijn J Braakhuis

  71. Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation

    Article • Oral Oncology, November 1997, Elsevier

    Dr Boudewijn J Braakhuis

  72. BIOLOGIC IMPLICATIONS OF GENETIC CHANGES IN HEAD AND NECK SQUAMOUS CELL CARCINOGENESIS

    Article • ANZ Journal of Surgery, July 1997, Wiley

    Dr Boudewijn J Braakhuis

  73. All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines

    Article • Oral Oncology, July 1997, Elsevier

    Dr Boudewijn J Braakhuis

  74. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines

    Article • British Journal of Cancer, July 1997, Nature

    Dr Boudewijn J Braakhuis

  75. Simultaneous analysis of retinol, all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction

    Article • Journal of Chromatography B Biomedical Sciences and Applications, June 1997, Elsevier

    Dr Boudewijn J Braakhuis

  76. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines

    Article • International Journal of Cancer, May 1997, Wiley

    Dr Boudewijn J Braakhuis

  77. A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts

    Article • Acta Oto-Laryngologica, January 1997, Taylor & Francis

    Dr Boudewijn J Braakhuis

  78. Cytomorphometric parameters in exfoliated cells as biomarkers in head and neck cancer chemoprevention

    Article • International Journal of Oncology, November 1996, Spandidos Publications

    Dr Boudewijn J Braakhuis

  79. Mutagen sensitivity: Enhanced risk assessment of squamous cell carcinoma

    Article • European Journal of Cancer Part B Oral Oncology, November 1996, Elsevier

    Dr Boudewijn J Braakhuis

  80. DNA-damage processing in blood lymphocytes of head-and-neck-squamous-cell-carcinoma patients is dependent on tumor site

    Article • International Journal of Cancer, September 1996, Wiley

    Dr Boudewijn J Braakhuis

  81. High mutagen sensitivity in head and neck squamous cell carcinoma (HNSCC) patients may be used for estimation of risk for second primary tumors

    Article • Mutation Research/Environmental Mutagenesis and Related Subjects, August 1996, Elsevier

    Dr Boudewijn J Braakhuis

  82. Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors

    Article • Cancer Chemotherapy and Pharmacology, July 1996, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  83. Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma

    Article • JNCI Journal of the National Cancer Institute, April 1996, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  84. POTENTIAL EARLY MARKERS OF CARCINOGENESIS IN THE MUCOSA OF THE HEAD AND NECK USING EXFOLIATIVE CYTOLOGY

    Article • The Journal of Pathology, March 1996, Wiley

    Dr Boudewijn J Braakhuis

  85. POTENTIAL EARLY MARKERS OF CARCINOGENESIS IN THE MUCOSA OF THE HEAD AND NECK USING EXFOLIATIVE CYTOLOGY

    Article • The Journal of Pathology, March 1996, Wiley

    Dr Boudewijn J Braakhuis

  86. Influence of the antioxidant N -acetylcysteine and its metabolites on damage induced by bleomycin in PM2 bacteriophage DNA

    Article • Carcinogenesis, January 1996, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  87. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma

    Article • Genes Chromosomes and Cancer, January 1996, Wiley

    Dr Boudewijn J Braakhuis

  88. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma

    Article • Genes Chromosomes and Cancer, January 1996, Wiley

    Dr Boudewijn J Braakhuis

  89. Bestimmung der genetischen Empfindlichkeit für die Entwicklung von Plattenepithelkarzinomen des Kopf-Hals-Bereichs mit bleomycin-induzierter chromosomaler Instabilität

    Article • Laryngo-Rhino-Otologie, December 1995, Thieme Publishing Group

    Dr Boudewijn J Braakhuis

  90. Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts

    Article • European Journal of Cancer, December 1995, Elsevier

    Dr Boudewijn J Braakhuis

  91. value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas

    Article • European Journal of Cancer Part B Oral Oncology, November 1995, Elsevier

    Dr Boudewijn J Braakhuis

  92. The role of glutathione S-transferases in head and neck squamous cell carcinogenesis

    Article • European Journal of Cancer Part B Oral Oncology, November 1995, Elsevier

    Dr Boudewijn J Braakhuis

  93. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma

    Article • Clinical Otolaryngology, October 1995, Wiley

    Dr Boudewijn J Braakhuis

  94. Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice

    Article • European Journal of Cancer, September 1995, Elsevier

    Dr Boudewijn J Braakhuis

  95. Antioxidant-related parameters in patients treated for cancer chemoprevention with N-acetylcysteine

    Article • European Journal of Cancer, June 1995, Elsevier

    Dr Boudewijn J Braakhuis

  96. Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: Potentiating or reversing effect?

    Article • International Journal of Cancer, May 1995, Wiley

    Dr Boudewijn J Braakhuis

  97. Role of Genetic Factors in the Etiology of Squamous Cell Carcinoma of the Head and Neck

    Article • Archives of Otolaryngology - Head and Neck Surgery, February 1995, American Medical Association (AMA)

    Dr Boudewijn J Braakhuis

  98. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Boudewijn J Braakhuis

  99. The growth inhibiting effect of docetaxel (Taxotere®) in head and neck squamous cell carcinoma xenografts

    Article • Cancer Letters, June 1994, Elsevier

    Dr Boudewijn J Braakhuis

  100. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors

    Article • International Journal of Cancer, March 1994, Wiley

    Dr Boudewijn J Braakhuis

  101. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma

    Article • Biochemical Pharmacology, December 1993, Elsevier

    Dr Boudewijn J Braakhuis

  102. Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer

    Article • Cancer Letters, November 1993, Elsevier

    Dr Boudewijn J Braakhuis

  103. In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis

    Article • British Journal of Cancer, October 1993, Nature

    Dr Boudewijn J Braakhuis

  104. A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials

    Article • Cancer, February 1993, Wiley

    Dr Boudewijn J Braakhuis

  105. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts

    Article • European Journal of Cancer, January 1993, Elsevier

    Dr Boudewijn J Braakhuis

  106. The Interval Between Methotrexate and Leucovorin Determines the Efficacy of 5-Fluorouracil Modulation in Vitro and in Vivo

    Article • January 1993, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  107. Variable Pharmacodynamics of Antifolates in Squamous Cell Carcinoma of the Head and Neck

    Article • January 1993, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  108. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG

    Article • British Journal of Cancer, September 1992, Nature

    Dr Boudewijn J Braakhuis

  109. Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984

    Article • Cancer Immunology Immunotherapy, July 1992, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  110. Growth of xenografted squamous cell carcinoma of the head and neck - possible correlation with patient survival

    Article • Apmis, July 1992, Wiley

    Dr Boudewijn J Braakhuis

  111. Carcinoembryonic antigen and head and neck cancer

    Article • Clinical Otolaryngology, April 1991, Wiley

    Dr Boudewijn J Braakhuis

  112. In vitro antiproliferative and metabolic activity of eight novel 5-fluorinated uracil nucleosides

    Article • European Journal of Cancer and Clinical Oncology, January 1991, Elsevier

    Dr Boudewijn J Braakhuis

  113. Antitumor activity of brequinar sodium (Dup-785) against human head and neck squanmous cell carcinoma xenografts

    Article • Cancer Letters, February 1990, Elsevier

    Dr Boudewijn J Braakhuis

  114. Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice

    Article • Head & Neck, November 1989, Wiley

    Dr Boudewijn J Braakhuis

  115. Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice

    Article • International Journal of Cancer, September 1989, Wiley

    Dr Boudewijn J Braakhuis

  116. Transplantability of Human Head and Neck Squamous Cell Carcinomas in Athymic Nude Mice

    Article • Archives of Otolaryngology - Head and Neck Surgery, September 1989, American Medical Association (AMA)

    Dr Boudewijn J Braakhuis

  117. An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent

    Article • European Journal of Nuclear Medicine and Molecular Imaging, May 1989, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  118. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes

    Article • British Journal of Cancer, March 1989, Nature

    Dr Boudewijn J Braakhuis

  119. Anti-tumor and differentiation-inducing activity of n,n-dimethylformamide (dmf) in head-and-neck cancer xenografts

    Article • International Journal of Cancer, February 1989, Wiley

    Dr Boudewijn J Braakhuis

  120. Fluoropyrimidine Metabolism in Human Head and Neck Cancer Xenografts and Murine Colon Tumors

    Article • January 1989, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  121. Preclinical antitumor activity of 5-aza-2′-deoxycytidine agains human head and neck cancer xenografts

    Article • Investigational New Drugs, December 1988, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  122. 114 FLUOROPYRIMIDINE METABOLISM IN HUMAN HEAD AND NECK CANCER XENOGRAFTS AND MURINE COLON TUMORS

    Article • Pediatric Research, July 1988, Nature

    Dr Boudewijn J Braakhuis

  123. Activity of Conventional Drugs in Head and Neck Cancer Xenografts

    Article • January 1988, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  124. Activity of Six New Drugs in Head and Neck Cancer Xenografts

    Article • January 1988, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  125. Activity of Differentiation-inducing Agents and Conventional Drugs in Head and Neck Cancer Xenografts

    Article • Acta Oto-Laryngologica, January 1988, Taylor & Francis

    Dr Boudewijn J Braakhuis

  126. Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice

    Article • British Journal of Cancer, July 1986, Nature

    Dr Boudewijn J Braakhuis

  127. Successful in vitro growth of human head and neck cancer after transplantation in nude mice

    Article • May 1985, Springer Science + Business Media

    Dr Boudewijn J Braakhuis

  128. Lack of Effect of Methotrexate on Human Head and Neck Tumours Transplanted in Athymic Nude Mice

    Article • Acta Oto-Laryngologica, January 1985, Taylor & Francis

    Dr Boudewijn J Braakhuis

  129. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate

    Article • British Journal of Cancer, November 1983, Nature

    Dr Boudewijn J Braakhuis

  130. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices

    Article • European Journal of Pharmacology, June 1980, Elsevier

    Dr Boudewijn J Braakhuis

  131. Therapeutic Effect of 5-Aza-2'-Deoxycytidine in Human Head and Neck Tumour Xenografts

    Article • Karger Publishers

    Dr Boudewijn J Braakhuis

  132. Chemotherapy of Human Head and Neck Tumors Transplanted in Athymic Nude Mice1

    Article • Karger Publishers

    Dr Boudewijn J Braakhuis